Harold L. Dauerman, MD

Extravascular Closure for Patients with High-Risk Femoral Anatomy

08/01/2008

Mitchell N. Rashid , MD;

Kristin Gilbert , BS;

Matthew W. Watkins , MD;

Edward F. Terrien , MD;

Bina Ahmed , MD;

Faye Straight , RN;

Harold L. Dauerman , MD;

Prospero B. Gogo Jr., MD, FACC, FSCAI;

Jason T. Bradley , MD;

Percutaneous femoral access is utilized for 7.5 million patients per year worldwide and vascular closure devices are used in approximately 2 million patients annually. All current vascular closure devices (VCDs) have been associated with...

Percutaneous femoral access is...

08/01/2008

Journal of Invasive Cardiology

Outcomes of Percutaneous Coronary Intervention Among Elderly Patients in Cardiogenic Shock: A Multicenter, Decade-Long Experienc

08/01/2008

Winthrop D. Piper , PhD;

Mirle A. Kellett , MD;

Samuel J. Shubrooks , MD;

John F. Robb , MD;

Michael J. Hearne , MD;

Matthew W. Watkins , MD;

Bruce D. Hettleman , MD;

Theodore Silver , MD;

Nathaniel W. Niles , MD;

David J. Malenka , MD;

Harold L. Dauerman , MD;

Thomas J. Ryan , MD;

Outcomes for patients with acute myocardial infarction (AMI) complicated by cardiogenic shock have improved in the setting of increased use of coronary revascularization during the 1990s.1,2 Consistent with these observations, the randomized...

Outcomes for patients with acute...

08/01/2008

Journal of Invasive Cardiology

Case Report

Complete Cypher‚Ñ¢ Stent Fracture and Migration in the Ostium of the Right Coronary Artery

08/01/2008

Jason T. Bradley , MD;

Joseph D. Schmoker , MD;

Harold L. Dauerman , MD;

J INVASIVE CARDIOL 2007;19:E99-E101 Stent fracture has been reported with the Cypher™ sirolimus-eluting stent (Cordis Corp., Miami, Florida) in 4 patients since the introduction of drug-eluting stents in 2004.1,2 In all of these cases, the...

J INVASIVE CARDIOL...

08/01/2008

Journal of Invasive Cardiology

Case Report

A Novel Use for a Distal Embolic Protection Device: Stent Retrieval

08/01/2008

Pavel Guigauri , MD;

Harold L. Dauerman , MD;

Stent embolization is an uncommon but potentially serious complication of percutaneous coronary intervention (PCI). The incidence of coronary stent embolization is 0.3–8.3% and varies with stent type, need for manual crimping, and clinical...

Stent embolization is an...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Consistent Door-to-Balloon Times of Less Than 90 Minutes for STEMI Patients Transferred for Primary PCI

09/01/2009

Bina Ahmed , MD;

Stefan Lischke , MD;

Faye Straight , RN;

Harold L. Dauerman , MD;

Prospero B. Gogo Jr., MD, FACC, FSCAI;

Stephen Leffler , MD;

Marc Kutler , MD;

David J. Schneider , MD;

ABSTRACT: Background. Recent data from large national registries show that

ABSTRACT: Background. Recent...

09/01/2009

Journal of Invasive Cardiology

Original Contribution

Angiographic Predictors of Vascular Complications Among Women Undergoing Cardiac Catheterization and Intervention

10/28/2010

Bina Ahmed , MD;

Stefan Lischke , MD;

Leigh Ann Holterman , BS ;

Faye Straight , RN;

Harold L. Dauerman , MD;

NULL

10/28/2010

Journal of Invasive Cardiology

Cath Lab Management

Extravascular Closure for Patients with High-Risk Femoral Anatomy

10/06/2008

Harold L. Dauerman , MD;

Prospero B. Gogo Jr., MD, FACC, FSCAI;

Mitchell N. Rashid , MD;

Kristin Gilbert , BS;

Edward F. Terrien , MD;

Jason T. Bradley , MD;

Bina Ahmed , MD;

Matthew W. Watkins , MD;

Faye Straight , RN;

Abstract Background. Vascular closure devices (VCDs) improve patient comfort and decrease time to ambulation. However, VCD studies have excluded patients with high-risk femoral artery anatomy; we examined the safety and efficacy of...

Abstract Background. Vascular...

10/06/2008

Cath Lab Digest

Original Contribution

Acute Kidney Injury and Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement

08/01/2021

Richard J. Solomon , MD;

Michael J. DeSarno , MS;

Martin M. LeWinter , MD;

Joshua Zimmer , MD;

Harold L. Dauerman , MD;

Newton Phuong , MD;

RAS inhibition after TAVR has been associated with lower cardiac mortality and heart failure readmissions. We analyzed 735 consecutive TAVR patients (2014-2019) who survived to hospital discharge at a high-volume TAVR center to determine the...

RAS inhibition after TAVR has...

08/01/2021

Journal of Invasive Cardiology